When comparing the expression levels of 2 genes between groups, we found that the high-risk CSCC group had significantly lower proportions of ACAP1 and RASGRP1 than the low-risk group in both the training and validation set (p < 0.05) (Fig. 2c). The gene discussed is ACAP1; the disease is skin squamous cell carcinoma.